1. Home
  2. CSW vs MIRM Comparison

CSW vs MIRM Comparison

Compare CSW & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSW Industrials Inc.

CSW

CSW Industrials Inc.

HOLD

Current Price

$307.24

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$78.82

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSW
MIRM
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CSW
MIRM
Price
$307.24
$78.82
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$309.25
$92.45
AVG Volume (30 Days)
174.8K
813.7K
Earning Date
01-29-2026
11-04-2025
Dividend Yield
0.35%
N/A
EPS Growth
15.78
N/A
EPS
8.52
N/A
Revenue
$964,795,000.00
$471,794,000.00
Revenue This Year
$25.92
$53.78
Revenue Next Year
$16.37
$19.91
P/E Ratio
$36.05
N/A
Revenue Growth
14.87
53.66
52 Week Low
$230.45
$36.88
52 Week High
$401.02
$82.58

Technical Indicators

Market Signals
Indicator
CSW
MIRM
Relative Strength Index (RSI) 61.60 62.89
Support Level $301.77 $63.23
Resistance Level $317.51 $82.58
Average True Range (ATR) 10.69 3.74
MACD -1.99 1.62
Stochastic Oscillator 52.24 81.03

Price Performance

Historical Comparison
CSW
MIRM

About CSW CSW Industrials Inc.

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: